SCHEMBL17690367

SCHEMBL17690367

OB(O)c1ccc(-c2ccc3[nH]c4ccccc4c3c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 2/20 0.50
AHR P35869 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 2/20 0.47
GPR3 P46089 1/20 0.47
KIF11 P52732 5/20 0.44
KMT2A Q03164 4/20 0.44
KDM4E B2RXH2 3/20 0.44
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 1/20 0.44
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
GABRP O00591 2/20 0.42
GABRD O14764 2/20 0.42
GABRA1 P14867 2/20 0.42
GABRB1 P18505 2/20 0.42
GABRG2 P18507 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenylboronic Acid SCHEMBL28203998 0.88 MGLL (0.67) MGLLAHRCA1CA2ALDH1A1
SCHEMBL28337113 0.87 MGLL (0.56) MGLLAHRCA1CA2ALDH1A1
SCHEMBL16394799 0.87 MGLL (0.55) MGLLAHRCA1CA2CDK4
SCHEMBL802744 0.86 AHR (0.57) AHRCA1CA2ALDH1A1HSD17B10
SCHEMBL29362586 0.86 AHR (0.57) AHRCA1CA2ALDH1A1HSD17B10
SCHEMBL19510163 0.86 AHR (0.67) AHRALDH1A1HSD17B10GPR3KIF11
SCHEMBL30799378 0.86 AHR (0.67) AHRALDH1A1HSD17B10GPR3KIF11
SCHEMBL16127349 0.84 AHR (0.70) AHRALDH1A1HSD17B10GPR3KIF11
SCHEMBL670060 0.84 AHR (0.70) AHRALDH1A1HSD17B10GPR3KIF11
SCHEMBL29511649 0.84 AHR (0.70) AHRALDH1A1HSD17B10GPR3KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10892419-B2 Space-through charge transfer compound, and organic light emitting diode and display device using the same LG DISPLAY CO., LTD. (KR) 2021-01-12 US disclosed
US-20190081244-A1 Space-Through Charge Transfer Compound, and Organic Light Emitting Diode and Display Device Using the Same LG DISPLAY CO., LTD. (KR) 2019-03-14 US disclosed
EP-3010064-B1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO LTD (KR) 2017-07-19 EP disclosed
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2016-04-21 US disclosed
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2016-04-21 US disclosed
EP-3010064-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG Display Co., Ltd. (KR) 2016-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10892419-B2 Space-through charge transfer compound, and organic light emitting diode and display device using the same NLRP1, NLRP3, CYBA MGLL 4523/4885AHR 313/4885CA1 2940/4885
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME NLRP1, NLRP3, CYBA MGLL 4523/4885AHR 313/4885CA1 2940/4885
US-20190081244-A1 Space-Through Charge Transfer Compound, and Organic Light Emitting Diode and Display Device Using the Same NLRP1, NLRP3, CYBA MGLL 4523/4885AHR 313/4885CA1 2940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.